This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/LSD
Revision as of 02:20, 8 May 2024 by >Quack (The current citation for the bioavailability for the Sublingual ROA is actually referencing the "... assuming [of] an oral bioavailability of 71%..." on page 5 and 6. Upon further research there exist a more concurrent article to contrast this figure, concluding a new bioavailability closer to 100% on page 1149.)
| SubstanceBox/LSD | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||
| Common names | LSD, LSD-25, Lucy, L, Acid, Cid, Tabs, Blotter | ||||||||||||||||||||||||||||||||||||||||
| Substitutive name | d-Lysergic acid diethylamide | ||||||||||||||||||||||||||||||||||||||||
| Systematic name | (6aR,9R)-N,N-Diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide | ||||||||||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||||||||||
| Psychoactive class | Psychedelic | ||||||||||||||||||||||||||||||||||||||||
| Chemical class | Lysergamide | ||||||||||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
- ↑ Grumann, Christina, et al. (January 2016). "Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration". Drug Testing and Analysis. 12 (8): 1144–1153. doi:https://doi.org/10.1002/dta.2821 Check
|doi=value (help).